Stockscreener 앱 받기
40.00
0.23%
0.09
전일 마감가:
$39.91
열려 있는:
$39.9
하루 거래량:
720.00K
Relative Volume:
1.18
시가총액:
$1.84B
수익:
$604.93M
순이익/손실:
$-31.91M
주가수익비율:
-16.53
EPS:
-2.42
순현금흐름:
$45.67M
1주 성능:
+5.49%
1개월 성능:
+16.58%
6개월 성능:
+24.69%
1년 성능:
-24.53%
1일 변동 폭
$39.27
$40.13
1주일 범위
$37.05
$40.28
52주 변동 폭
$23.91
$55.63
Azenta Inc Stock (AZTA) Company Profile
명칭
Azenta Inc
전화
(978) 262-2400
주소
200 SUMMIT DRIVE, BURLINGTON
AZTA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AZTA
Azenta Inc
|
40.00 | 1.84B | 604.93M | -31.91M | 45.67M | -2.42 |
|
ISRG
Intuitive Surgical Inc
|
535.00 | 191.90B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
207.11 | 59.36B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
79.00 | 39.13B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
257.58 | 38.05B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
MDLN
Medline Inc
|
44.12 | 33.62B | 27.43B | 1.27B | 1.01B | 1.5829 |
Azenta Inc Stock (AZTA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-05 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2025-12-19 | 재확인 | Needham | Buy |
| 2025-10-30 | 업그레이드 | Jefferies | Hold → Buy |
| 2025-08-06 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2025-07-22 | 재개 | Stephens | Equal-Weight |
| 2024-12-18 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2024-04-04 | 개시 | Jefferies | Hold |
| 2024-02-01 | 재확인 | B. Riley Securities | Buy |
| 2023-07-19 | 개시 | Raymond James | Mkt Perform |
| 2023-05-10 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-02-09 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2023-01-03 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2022-03-31 | 재개 | B. Riley Securities | Buy |
| 2022-03-21 | 개시 | Evercore ISI | Outperform |
모두보기
Azenta Inc 주식(AZTA)의 최신 뉴스
Azenta, Inc. (AZTA) Stock Analysis: Exploring a 15.88% Upside Potential in the Healthcare Sector - DirectorsTalk Interviews
IBD rating upgrades: Azenta flashes improved price strength - MSN
Conestoga Capital Advisors LLC Sells 450,370 Shares of Azenta, Inc. $AZTA - MarketBeat
Azenta, Inc. (NASDAQ:AZTA) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Azenta Delays 10-K Filing Due to Accounting Revisions - MSN
Why Azenta (AZTA) Got an Analyst Upgrade After Mixed Results and What It Implies for Automation - Sahm
Why Azenta Inc. stock is seen as undervalued2025 Big Picture & Community Verified Trade Alerts - Улправда
TD Cowen Raises Azenta (NASDAQ:AZTA) Price Target to $39.00 - MarketBeat
Azenta (AZTA) Analyst Rating Maintained, Price Target Raised to $39 by TD Cowen | AZTA Stock News - GuruFocus
Buyback Watch: How Azenta Inc. stock performs in rising dollar environmentTrade Analysis Summary & Low Drawdown Investment Strategies - Улправда
Market Outlook: Will Azenta Inc. stock deliver consistent dividendsJuly 2025 Chart Watch & Expert Approved Trade Ideas - Улправда
Azenta, Inc. (AZTA) Stock Analysis: Exploring a 19.81% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Why Are Azenta (AZTA) Shares Soaring Today - Finviz
Azenta Enters Agreement for the Sale of its B Medical Systems Business to THELEMA S.À R.L. - citybiz
Allspring Global Investments Holdings LLC Cuts Stock Holdings in Azenta, Inc. $AZTA - MarketBeat
Azenta (NASDAQ:AZTA) Rating Increased to Buy at Wall Street Zen - MarketBeat
Bear of the Day: Azenta (AZTA) - The Globe and Mail
Vale and Azenta have been highlighted as Zacks Bull and Bear of the Day - Yahoo Finance
Azenta divests B Medical Systems to streamline portfolio - The Globe and Mail
Azenta enters agreement for sale of B Medical Systems to THELEMA for $63M - Yahoo Finance
Azenta to sell B Medical Systems business for $63 million By Investing.com - Investing.com Nigeria
Azenta Signs Sale And Purchase Agreement With Thelema - TradingView — Track All Markets
Azenta to sell B Medical Systems business for $63 million - Investing.com
Azenta (AZTA) to Divest B Medical Systems for $63 Million - GuruFocus
Azenta Enters Definitive Agreement for the Sale of its B Medical Systems Business to THELEMA S.À R.L. - PR Newswire
Azenta (AZTA): Buy, Sell, or Hold Post Q3 Earnings? - Barchart.com
How Azenta Inc. (BA3) stock stacks up against competitorsMarket Volatility Update & Big Returns, Small Investment - bollywoodhelpline.com
What analyst consensus implies for Azenta Inc. (BA3) stock2025 Price Momentum & Free Low Drawdown Momentum Trade Ideas - Улправда
Is Azenta’s Buyback and M&A Push Recalibrating the Investment Case For Azenta (AZTA)? - simplywall.st
Pharma News: Is Azenta Inc. stock a top pick in earnings seasonMarket Trend Report & Weekly High Potential Stock Alerts - moha.gov.vn
Needham Sticks to Their Buy Rating for Azenta (AZTA) - The Globe and Mail
Stock Market Recap: How Azenta Inc. stock performs after earningsJuly 2025 Technicals & Real-Time Buy Zone Alerts - Улправда
Azenta, Inc. ($AZTA) CEO 2025 Pay Revealed - Quiver Quantitative
How Azenta Inc. stock compares to industry benchmarksMarket Sentiment Review & Verified Short-Term Trading Plans - Улправда
Hedge Fund Moves: How strong is Azenta Inc. stock balance sheetJuly 2025 Highlights & Low Risk High Reward Ideas - Улправда
Form DEFR14A Azenta, Inc. - StreetInsider
Azenta (STU:BA3) EV-to-OCF : 16.73 (As of Dec. 19, 2025) - GuruFocus
Is Azenta Inc. stock a top pick in earnings seasonWeekly Stock Summary & Free Growth Oriented Trading Recommendations - Улправда
Azenta (NASDAQ:AZTA) Price Target Raised to $44.00 at Needham & Company LLC - MarketBeat
Azenta (AZTA): Needham Analyst Raises Price Target to $44 | AZTA Stock News - GuruFocus
Needham Raises Price Target on Azenta to $44 From $42, Keeps Buy Rating - marketscreener.com
Azenta, Inc. $AZTA Shares Sold by Squarepoint Ops LLC - MarketBeat
Will Azenta Inc. stock benefit from green energy trendsWeekly Profit Analysis & Verified Technical Signals - Bölüm Sonu Canavarı
How Azenta Inc. stock performs in rising dollar environmentSell Signal & Reliable Intraday Trade Alerts - Улправда
Azenta (NASDAQ: AZTA) outlines 2026 meeting, equity plan and governance - Stock Titan
Azenta, Inc. Announces Directors Not Nominated for Re-Election - marketscreener.com
How strong is Azenta Inc. stock balance sheetWeekly Trade Review & Accurate Buy Signal Notifications - Улправда
How Azenta Inc. stock benefits from tech adoptionTrade Exit Report & High Accuracy Swing Entry Alerts - Улправда
Azenta (AZTA) price target increased by 15.88% to 39.34 - MSN
Azenta Inc (AZTA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Azenta Inc 주식 (AZTA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Lin Lawrence Y. | EVP, CFO and Treasurer |
Aug 11 '25 |
Buy |
27.96 |
2,500 |
69,900 |
46,013 |
| Hughes Violetta | VP, Chief Accounting Officer |
Feb 03 '25 |
Sale |
52.97 |
317 |
16,791 |
9,603 |
| Zhou Ginger | SVP and General Manager, Genom |
Jan 31 '25 |
Buy |
45.88 |
417 |
19,132 |
27,916 |
0.01%
1.19%
자본화:
|
볼륨(24시간):